[go: up one dir, main page]

SE8404130D0 - NEW INJECTABLE COMPOSITIONS - Google Patents

NEW INJECTABLE COMPOSITIONS

Info

Publication number
SE8404130D0
SE8404130D0 SE8404130A SE8404130A SE8404130D0 SE 8404130 D0 SE8404130 D0 SE 8404130D0 SE 8404130 A SE8404130 A SE 8404130A SE 8404130 A SE8404130 A SE 8404130A SE 8404130 D0 SE8404130 D0 SE 8404130D0
Authority
SE
Sweden
Prior art keywords
injectable compositions
microns
particles
maximum dimension
new injectable
Prior art date
Application number
SE8404130A
Other languages
Swedish (sv)
Other versions
SE8404130L (en
SE460095B (en
Inventor
J H Bell
R P Haslam
A Lewis
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE8404130D0 publication Critical patent/SE8404130D0/en
Publication of SE8404130L publication Critical patent/SE8404130L/en
Publication of SE460095B publication Critical patent/SE460095B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A sterile, substantially neutral aqueous injectable suspension comprises up to approximately 80% w/v of metronidazole, the metronidazole being in the form of particles having a median maximum dimension of from 15 to 30 microns and containing not more than about 10% by weight of particles having a maximum dimension of 10 microns or less and not more than about 10% by weight of particles having a maximum dimension of 80 microns or greater.
SE8404130A 1983-08-19 1984-08-17 INJECTABLE COMPOSITION CONTAINING 1- (2-HYDROXYETHYL) -2-METHYL-5-NITROIMIDAZOLE AND PACKAGING FOR PREPARATION OF THEREOF SE460095B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (3)

Publication Number Publication Date
SE8404130D0 true SE8404130D0 (en) 1984-08-17
SE8404130L SE8404130L (en) 1985-02-20
SE460095B SE460095B (en) 1989-09-11

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404130A SE460095B (en) 1983-08-19 1984-08-17 INJECTABLE COMPOSITION CONTAINING 1- (2-HYDROXYETHYL) -2-METHYL-5-NITROIMIDAZOLE AND PACKAGING FOR PREPARATION OF THEREOF

Country Status (17)

Country Link
JP (1) JPS6067468A (en)
AU (1) AU577055B2 (en)
BE (1) BE900381A (en)
CA (1) CA1214727A (en)
CH (1) CH662812A5 (en)
DE (1) DE3430354A1 (en)
DK (1) DK165817C (en)
FR (1) FR2560043B1 (en)
GB (2) GB8322364D0 (en)
HU (1) HU192990B (en)
IL (1) IL72714A (en)
IT (1) IT1213208B (en)
LU (1) LU85511A1 (en)
NL (1) NL8402510A (en)
NZ (1) NZ209270A (en)
SE (1) SE460095B (en)
ZA (1) ZA846431B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (en) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimycotic tablets contg. micronised azole derivs. - together with acid and/or buffer

Also Published As

Publication number Publication date
DK165817B (en) 1993-01-25
DK397084D0 (en) 1984-08-17
AU3202284A (en) 1985-02-21
NL8402510A (en) 1985-03-18
SE8404130L (en) 1985-02-20
GB8420959D0 (en) 1984-09-19
IT1213208B (en) 1989-12-14
LU85511A1 (en) 1985-04-24
GB2145088B (en) 1986-10-08
IT8422323A0 (en) 1984-08-13
GB8322364D0 (en) 1983-09-21
NZ209270A (en) 1988-02-29
CH662812A5 (en) 1987-10-30
BE900381A (en) 1985-02-18
JPS6067468A (en) 1985-04-17
ZA846431B (en) 1985-03-27
IL72714A (en) 1988-09-30
SE460095B (en) 1989-09-11
DE3430354A1 (en) 1985-03-07
FR2560043B1 (en) 1988-08-05
CA1214727A (en) 1986-12-02
GB2145088A (en) 1985-03-20
AU577055B2 (en) 1988-09-15
HU192990B (en) 1987-08-28
DK165817C (en) 1993-06-21
DK397084A (en) 1985-02-20
HUT35650A (en) 1985-07-29
FR2560043A1 (en) 1985-08-30

Similar Documents

Publication Publication Date Title
ATE41308T1 (en) SUCRALFATE SUSPENSION.
NO832749L (en) PUMPABLE CONCENTRATED POLYMER SUSPENSIONS.
YU74593A (en) NEW TAXOID BASED MIXTURES
ATE208621T1 (en) STABILIZATION OF PROSTAGLAND COMPOSITIONS
ES8602946A1 (en) Polymer suspensions.
ES2162139T3 (en) VACCINE COMPOSITIONS CONTAINING MONOFOSFORIL-LIPIDO TO 3-O-DISABLED.
ITRM920489A1 (en) PROCEDURE TO AVOID THE INSTABILITIES OF ROAD BEHAVIOR OF VEHICLES.
DE68906413D1 (en) AMINE-ION PAIR COMPLEX CONDITIONING CONTAINER AND COMPOSITIONS CONTAINING THEREOF.
ATE22774T1 (en) PLANT PROTECTION PRODUCTS IN THE FORM OF MIXED DISPERSIONS.
IT8348006A0 (en) THEIR PRODUCTION OF CEPHALOSPORIN DERIVATIVES AND ANTIBACTERIAL COMPOSITIONS THAT CONTAIN THEM, AS WELL AS PROCEDURE FOR THE
IT7967447A0 (en) AQUEOUS SUSPENSION AND PROCEDURE FOR THE MANUFACTURE OF PARTICLE CLEANING COMPOSITIONS
IT1116833B (en) PIRIVA DERIVATIVES EQUIPPED WITH DE VON ADRENERGIC ACTIVATORS
FR2548676B1 (en) BIOPOLYMER COMPOSITIONS AND THEIR PREPARATION PROCESS
KR880013557A (en) New Ophthalmic Compositions
SE8404130D0 (en) NEW INJECTABLE COMPOSITIONS
DK0422998T3 (en) Aqueous zeolite suspension containing a siliconate
BE893025A (en) DERIVATIVES OF 1,4-THIAZANE-CARBOXILIC ACID, THEIR PREPARATION AND USE AS WELL AS THE COMPOSITIONS CONTAINING THESE DERIVATIVES.
ES8500928A1 (en) Oxaspirododecane compounds, their preparation and their use as perfumes, and perfume compositions containing them.
FI853957A7 (en) Compositions especially for improving the properties of vulcanizates and for strengthening natural and synthetic rubbers.
ES8702162A1 (en) Self-emulsionable compositions based on fluorochlorohydrocarbons and phosphoric esters.
IT1230053B (en) COMPOSITION FOR THE INCREASE OF THE WEIGHT GAIN.
IT9002117A0 (en) PROCEDURE FOR THE APPLICATION OF THE SPUR AND FOOTWEAR MADE ACCORDING TO THE PROCEDURE.
SU1648039A1 (en) METHOD FOR STABILIZING PROPYLENE TRIMERS
SU1207006A1 (en) PROTECTIVE ENVIRONMENT FOR LYOPHYLIZATION OF ERYTHROCYTIC DIAGNOSTICUM
IT1198692B (en) METHOD TO PROTECT DELICATE ARTIFACTS, SUCH AS SOCKS, COMPARED TO THE PACKAGING ENVELOPE

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404130-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404130-0

Format of ref document f/p: F